News Daily News ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events Michael O'Riordan April 04, 2017
News Daily News Timing and Dose Matters When It Comes to Statin Therapy Before CABG Surgery Michael O'Riordan March 16, 2017
News Daily News Statin-Intolerant Patients Have Significantly Worse Prognosis After MI Michael O'Riordan March 13, 2017
News Daily News Coronary Calcium IDs Higher Heart Disease Risk Even in Younger Adults Todd Neale February 10, 2017
News Daily News Alirocumab to Remain On Market While Companies Clash Over Patents Michael O'Riordan February 09, 2017
News Daily News E-Cigarettes May Increase CV Disease Risk Just Like the Real Thing L.A. McKeown February 03, 2017
News Daily News Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint Michael O'Riordan February 03, 2017
News Daily News How Low Can Cholesterol Go? Safety Not in Limbo for Patients With Very Low LDL on Alirocumab, Study Shows Yael L. Maxwell January 31, 2017
News Daily News American Heart Association Annual Stats: Yet Again, CVD Is the Leading Killer Shelley Wood January 26, 2017
News Daily News Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy Michael O'Riordan January 18, 2017
News Daily News Younger Adults With Severe Dyslipidemia Less Likely to Be Prescribed Statins Michael O'Riordan January 05, 2017
News Daily News High-Sensitivity Troponin Assays May Help With Response to Statins and Other Meds Todd Neale December 19, 2016
News Daily News Prior Atherosclerosis Ups the Risk of Dying After Acute MI Michael O'Riordan December 09, 2016
News Daily News PCSK9 Variants Linked With Lower LDL Cholesterol, Increased Diabetes Risk Michael O'Riordan December 01, 2016
News Daily News Lipid Losses: National Data Show Drastic Drops in Total Cholesterol, Triglycerides, and LDL Yael L. Maxwell November 30, 2016
News Daily News New USPSTF Guidelines Recommend Statins in ‘Appropriately Selected’ Primary-Prevention Patients Michael O'Riordan November 13, 2016
News Daily News High-Intensity Statin Therapy Offers Survival Benefit Over Moderate-Intensity Statins in CVD Patients Michael O'Riordan November 10, 2016